Longitudinal Corneal Endothelial Cell Changes in Patients Undergoing Hematopoietic Stem Cell Transplantation

被引:7
作者
Pellegrini, Marco [1 ,2 ]
Giannaccare, Giuseppe [3 ]
Bernabei, Federico [1 ,2 ]
Moscardelli, Fabiana [1 ,2 ]
Sessa, Mariarosaria [2 ,4 ]
Arpinati, Mario [2 ,4 ]
Bonifazi, Francesca [1 ,2 ]
Versura, Piera [1 ,2 ]
机构
[1] Univ Bologna, Alma Mater Studiorum, Ophthalmol Unit, DIMES, Bologna, Italy
[2] S Orsola Malpighi Teaching Hosp, Bologna, Italy
[3] Magna Graecia Univ Catanzaro, Dept Ophthalmol, Catanzaro, Italy
[4] Univ Bologna, Hematol Unit, DIMES, Alma Mater Studiorum, Bologna, Italy
关键词
hematopoietic stem cell transplantation; ocular graft versus host disease; corneal endothelium; GVHD; dry eye; VERSUS-HOST-DISEASE;
D O I
10.1097/ICO.0000000000002441
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To evaluate longitudinally corneal endothelial cell changes in patients undergoing hematopoietic stem cell transplantation (HSCT) and to further investigate possible correlations with hematological and ocular characteristics. Methods: Prospective observational study conducted at a single center. All patients underwent a comprehensive ophthalmological examination, before and after HSCT, including slitlamp examination, Schirmer test, tear breakup time, ocular surface staining, specular microscopy of corneal endothelium, and Ocular Surface Disease Index questionnaire. Results: Twenty-five patients undergoing HSCT and 25 age- and sex-matched controls were included. At baseline, hematological patients showed significantly lower values of endothelial cell density (ECD) compared with those of controls (2514.5 +/- 390.2 vs. 2723.7 +/- 298.0 cells/mm(2), P = 0.038). After HSCT, ocular surface disease index score significantly increased (P = 0.020) and tear breakup time significantly decreased (P = 0.036). Conversely, no significant changes were found in Schirmer test and corneal fluorescein staining (always P > 0.05). Eight patients (32%) developed ocular graft-versus-host disease (GVHD). ECD values significantly decreased after HSCT (from 2514.5 +/- 390.2 to 2409.5 +/- 330.9 cells/mm(2), P = 0.009). The decrease in ECD values after HSCT was more pronounced in patients with ocular GVHD compared with those without (231.1 +/- 188.8 vs. 45.6 +/- 156.5, P = 0.016). No significant correlations between the changes in ECD and hematological and ocular characteristics were found (always P > 0.05). Conclusions: Hematological patients showed a lower endothelial cell count already before HSCT, compared with controls. After HSCT, the endothelial cell count further significantly decreased, particularly in patients who developed ocular GVHD.
引用
收藏
页码:462 / 466
页数:5
相关论文
共 50 条
  • [31] Physical exercise as adjuvant therapy for patients undergoing hematopoietic stem cell transplantation
    J Wiskemann
    G Huber
    [J]. Bone Marrow Transplantation, 2008, 41 : 321 - 329
  • [32] Clostridium Difficile Colonization and Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation
    Bruminhent, Jackrapong
    Wang, Zi-Xuan
    Hu, Carol
    Wagner, John
    Sunday, Richard
    Bobik, Brent
    Hegarty, Sarah
    Keith, Scott
    Alpdogan, Seyfettin
    Carabasi, Matthew
    Filicko-O'Hara, Joanne
    Flomenberg, Neal
    Kasner, Margaret
    Outschoorn, Ubaldo Martinez
    Weiss, Mark
    Flomenberg, Phyllis
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (09) : 1329 - 1334
  • [33] Utility of surveillance blood cultures in patients undergoing hematopoietic stem cell transplantation
    Sameeh S Ghazal
    Michael P Stevens
    Gonzalo M Bearman
    Michael B Edmond
    [J]. Antimicrobial Resistance and Infection Control, 3
  • [34] Cognitive function in patients prior to undergoing allogeneic hematopoietic stem cell transplantation
    Zev M. Nakamura
    Allison M. Deal
    Donald L. Rosenstein
    Laura J. Quillen
    Stephanie A. Chien
    William A. Wood
    Thomas C. Shea
    Eliza M. Park
    [J]. Supportive Care in Cancer, 2021, 29 : 2007 - 2014
  • [35] Effectiveness of Physical Exercise in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
    Lim, Su Jin
    Lee, So Young
    Oh, Euigeum
    [J]. ASIAN ONCOLOGY NURSING, 2012, 12 (03) : 195 - 203
  • [36] Rationale for Hickman catheter removal in patients undergoing hematopoietic stem cell transplantation
    Castanho, Lais Carvalho
    Campos Pereira Silveira, Renata Cristina
    Merizio Martins Braga, Fernanda Titareli
    Marin da Silva Canini, Silvia Rita
    Diniz Reis, Paula Elaine
    Voltarelli, Julio Cesar
    [J]. ACTA PAULISTA DE ENFERMAGEM, 2011, 24 (02) : 244 - 248
  • [37] Population pharmacokinetics analysis of cyclophosphamide with genetic effects in patients undergoing hematopoietic stem cell transplantation
    Kim, In-Wha
    Yun, Hwi-yeol
    Choi, Boyoon
    Han, Nayoung
    Kim, Myeong Gyu
    Park, Seonyang
    Oh, Jung Mi
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (08) : 1543 - 1551
  • [38] Endothelial Dysfunction in Hematopoietic Cell Transplantation
    Marta Palomo
    Maribel Diaz-Ricart
    Enric Carreras
    [J]. Clinical Hematology International, 2019, 1 (1) : 45 - 51
  • [39] Evaluation of sleep disorders before and after transplantation in patients undergoing hematopoietic stem cell transplantation
    Yavlal, F.
    Aras, Y. G.
    Ulas, S. B.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (23) : 8935 - 8944
  • [40] Endothelial Function in Patients with Hematologic Malignancies Undergoing High-Dose Chemotherapy Followed by Hematopoietic Stem Cell Transplantation
    Poreba, Malgorzata
    Gac, Pawel
    Usnarska-Zubkiewicz, Lidia
    Pilecki, Witold
    Kuliczkowski, Kazimierz
    Mazur, Grzegorz
    Sobieszczanska, Malgorzata
    Poreba, Rafal
    [J]. CARDIOVASCULAR TOXICOLOGY, 2016, 16 (02) : 156 - 162